Testing effectiveness (Phase 2)UnknownNCT06092606
What this trial is testing
Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
Who this might be right for
CancerHeart FailureArrhythmia+2 more
Monyan Pharmaceutical (Shanghai) Co., Ltd. 90